PB Ratio: 2.32

Basis: FMP quote market capitalization / book value attributable to common shareholders (matching reported total stockholders equity minus preferred stock). Source: stored company filings and market data; unavailable inputs remain N/A.

Is the P/B ratio high or low?

The P/B ratio of 2.32 is in line with its estimated 2-year average of 2.12, around the middle of its estimated 2-year range (1.03–3.75).

As of 2026-10-06T20:30:44.222Z. 13.49% below its estimated 12-month average of 2.68.

BCAX PB Ratio Metrics

P/B vs. estimated history

At 2.32, P/B is near its estimated 2-year median — higher than 62% of readings in its estimated 2-year history.

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

Book Value Analysis

PB Ratio Formula & Definition

PB Ratio = Market Cap / (Total Shareholders' Equity − Preferred Stock)

The price-to-book ratio compares market capitalization to book value attributable to common shareholders (total equity minus preferred stock). Lower values can indicate a cheaper valuation relative to net assets.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PB Ratio FAQ

What is the P/B ratio for Bicara Therapeutics Inc. Common Stock (BCAX)?

The P/B ratio for BCAX stock is 2.32.

Is Bicara Therapeutics Inc. Common Stock's P/B ratio high or low?

The P/B ratio of 2.32 is in line with its estimated 2-year average of 2.12, around the middle of its estimated 2-year range (1.03–3.75).

What is the estimated TTM average P/B ratio for Bicara Therapeutics Inc. Common Stock (BCAX)?

The estimated TTM average P/B ratio for BCAX stock is 2.68.

Showing the most recent 260 of 473 data points. The chart above shows the full history.

Related Metrics